Uslu Gokceoglu Arife, Akman Sema, Koyun Mustafa, Comak Elif, Dogan Cagla Serpil, Akbas Halide, Dinckan Ayhan
Department of Pediatric Nephrology, Akdeniz University Medical Faculty, Antalya 07070, Turkey.
Exp Clin Transplant. 2013 Dec;11(6):489-93. doi: 10.6002/ect.2013.0012.
We sought to evaluate the prevalence and confounding clinical variables of hyperuricemia in pediatric kidney transplant patients.
We retrospectively evaluated the medical records of 151 pediatric renal transplant recipients who received their grafts at Akdeniz University Medical Faculty in Antalya, Turkey, with a follow-up longer than 6 months. This retrospective, single-center study included 117 pediatric renal transplant recipients, after we had excluded the patients with changes in immunosuppressive treatment and graft loss, who were receiving therapy with allopurinol and furosemide. Patient information and laboratory data were obtained from patient charts and an electronic hospital database.
Mean uric acid levels of patients were 311 ± 74 μmol/L, and 24 of all of the patients (20%) had high uric acid levels. Fifteen patients taking tacrolimus (16%), and 9 of patients taking cyclosporine (39%) had hyperuricemia. The hyperuricemia rate of patients taking cyclosporine was significantly higher than it was for those patients taking tacrolimus (P = .014). Mean levels of uric acid in patients taking cyclosporine were higher than those of patients taking tacrolimus (344 ± 62 μmol/L and 303 ± 75 μmol/L; P = .006). There was a significant positive correlation between mean uric acid concentrations, and both serum creatinine (P = .000; r=0.487) and cystatin C (P = .000; r=0.433). There was negative correlation between mean uric acid concentration and estimated glomerular filtration rate (P = .000; r=-0.417). Mean uric acid levels of patients with intact graft function (estimated glomerular filtration rate ≥ 60 mL/min/1.73 m²) was lower than the patients with a low estimated glomerular filtration rate (291 ± 67 μmol/L and 353 ± 71 μmol/L; P = .000). Mean uric acid level of patients with normal body mass index was significantly lower than that of patients who were obese-overweight (301 ± 64 μmol/L vs 343 ± 94 μmol/L; P = .045).
We found 20% of our patient group had high uric acid levels. We also found that lower glomerular filtration rate, higher serum creatinine, cystatin c, obesity, and being overweight were risk factors for hyperuricemia in pediatric renal transplant recipients.
我们试图评估小儿肾移植患者高尿酸血症的患病率及相关混杂临床变量。
我们回顾性评估了151例在土耳其安塔利亚的阿克德尼兹大学医学院接受移植且随访时间超过6个月的小儿肾移植受者的病历。在排除免疫抑制治疗有变化及移植失败的患者,以及正在接受别嘌醇和呋塞米治疗的患者后,这项回顾性单中心研究纳入了117例小儿肾移植受者。患者信息和实验室数据来自患者病历及医院电子数据库。
患者的平均尿酸水平为311±74μmol/L,所有患者中有24例(20%)尿酸水平较高。15例服用他克莫司的患者(16%)以及9例服用环孢素的患者(39%)患有高尿酸血症。服用环孢素患者的高尿酸血症发生率显著高于服用他克莫司的患者(P = 0.014)。服用环孢素患者的平均尿酸水平高于服用他克莫司的患者(344±62μmol/L和303±75μmol/L;P = 0.006)。平均尿酸浓度与血清肌酐(P = 0.000;r = 0.487)和胱抑素C(P = 0.000;r = 0.433)均呈显著正相关。平均尿酸浓度与估计肾小球滤过率呈负相关(P = 0.000;r = -0.417)。移植肾功能正常(估计肾小球滤过率≥60 mL/min/1.73 m²)患者的平均尿酸水平低于估计肾小球滤过率低的患者(291±67μmol/L和353±71μmol/L;P = 0.000)。体重指数正常患者的平均尿酸水平显著低于肥胖-超重患者(301±64μmol/L对343±94μmol/L;P = 0.045)。
我们发现患者组中有20%尿酸水平较高。我们还发现较低的肾小球滤过率、较高的血清肌酐、胱抑素C、肥胖及超重是小儿肾移植受者高尿酸血症的危险因素。